...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith funding???

Thanks for the background RVXoldtimer. Your posts are valuable to me because you have a great understanding of the financial side and provide excellent detective work. NBB I like your thinking. I keep going back to the mCRPC graph and scatch my head waiting for an analysis and presentation. The results look very promising but these BPs eeem very conservative. I'd like to see something on a concrete deal and then perhaps some liquidity or pay out of some sort. I've become a bit frustrated over recent years having been in this for about 10 years but it's science and science has it's own pace so I must be patient. Thanks for the insights. GLTA  Toinv

Share
New Message
Please login to post a reply